Eran Broshy has served as a Certara director since 2022, sitting on the Audit Committee and chairing the Nominating and Corporate Governance Committee. He was CEO of Syneos Health (formerly inVentiv Health) until 2008 and its Chair until 2010, and earlier spent roughly 15 years at The Boston Consulting Group leading its Americas healthcare practice. He serves on the board of Theravance Biopharma, has partnered with private equity firms including EQT and Nordic Capital, and holds a B.S. from MIT, an M.S. from Stanford and an MBA from Harvard.